Amneal Pharmaceuticals Inc.
AMRX | NASDAQ
$19.20
-$0.96 (-4.76%)
Sep 22, 2026, 1:21 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 215.32M | 181.32M | 127.93M | 57.62M | 51.24M | 21.63M | -84.67M | -157.27M | -144M | -120.31M | -48.72M | 40.29M | 12.57M | -257.2M | -249.26M | -251.3M | -252.85M | 1.76M | 10.62M | 13.96M | 9.23M | -29.25M |
Depreciation & Amortization | 151.1M | 163.41M | 223.57M | 240.48M | 245.36M | 248.27M | 243.64M | 234.44M | 232.69M | 226.78M | 229.4M | 235.63M | 242.13M | 244.72M | 244.38M | 244.73M | 241.21M | 238M | 235.74M | 234.33M | 235.73M | 237.32M |
Stock-Based Compensation | 26.81M | 24.7M | 31.95M | 30.96M | 29.85M | 28.3M | 27.77M | 26.53M | 26.11M | 25.95M | 26.82M | 28.68M | 29.68M | 31.38M | 23.78M | 23.69M | 16M | 7.74M | 7.74M | 5.13M | 10.55M | 16.21M |
Other Working Capital | -68.01M | -71.1M | -18.23M | 18.16M | 47.56M | 57.99M | 53.42M | 36.87M | 13.97M | 10.6M | 47.64M | 73.99M | 159.81M | 42.88M | 12.76M | -25.01M | -108.57M | -27.38M | -24.23M | -16.22M | -1.8M | 61.29M |
Other Non-Cash Items | 103.27M | 246.01M | 184.41M | 192.43M | 101.48M | 167.04M | 172.28M | 241.22M | 247.23M | 182.48M | 185.26M | 62.09M | -54.42M | -42.49M | -102.24M | -82.61M | 35.57M | 49.4M | 110.2M | 93.21M | 214.3M | 193.8M |
Deferred Income Tax | -23.36M | -23.36M | -23.36M | -23.36M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -253.11M | -288.22M | -204.52M | -170.37M | -76.87M | -158.33M | -63.92M | -32.08M | -109.58M | -113.44M | -47.19M | -180.23M | -31.31M | 108.06M | 104.43M | 173.14M | 56.51M | -126.86M | -122.48M | -62.11M | -222.88M | 60.03M |
Operating Cash Flow | 220.04M | 303.86M | 339.99M | 327.76M | 351.08M | 306.92M | 295.1M | 312.84M | 252.46M | 201.46M | 345.58M | 186.46M | 198.65M | 84.47M | 21.1M | 107.66M | 96.45M | 170.04M | 241.82M | 284.52M | 246.93M | 478.1M |
Capital Expenditures | -72.08M | -98.58M | -103.04M | -82.94M | -88.6M | -72.8M | -74.24M | -82.87M | -75.63M | -77.21M | -69.19M | -48.96M | -53.02M | -57.85M | -56.91M | -63.49M | -56.61M | -47.3M | -48.28M | -60.93M | -65.5M | -66.25M |
Cash Acquisitions | 715K | 1.57M | 1.57M | 7.86M | 7.86M | 7.01M | 7.01M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -84.71M | -157.43M | -157.43M | -231.26M | -146.54M | -73.83M | -71.19M | 2.27M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -7.41M | -7.41M | -12.05M | -12.65M | -8.84M | -4.6M | -9.66M | -28.96M | -26.36M | -31.75M | -22.39M | -2.49M | -33.29M | -41.14M | -42.69M | -38.89M | -8.08M | 174K | 1.15M | -3.76M | -4.97M | -4.22M |
Investing Cash Flow | -89.63M | -116.18M | -112.26M | -82.87M | -81.12M | -61.03M | -63M | -78.63M | -71.39M | -77.21M | -69.19M | -48.96M | -84.82M | -88.65M | -174.31M | -249.81M | -212.11M | -278.88M | -194.18M | -139.01M | -142.16M | -68.2M |
Debt Repayment | 54.92M | 37.63M | 26.27M | -23.14M | -177.57M | -187.27M | -185.12M | -65.42M | -32.16M | -66K | 22.65M | -59.16M | -47.83M | -21.14M | -38.27M | -30.46M | -22.22M | -66.25M | -79.18M | -79.04M | -54.38M | -352.31M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | -194K | -353K | -353K | -353K | -159K | n/a | n/a | -88K | -280K | -280K | -280K | -261K | -69K | -69K | -69K | -68K | -306K | -306K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -63.91M | -88.99M | -59.76M | -60.88M | -57.4M | -40.25M | -26.35M | -185.67M | -213.37M | -222.79M | -235.23M | -74.66M | -45.35M | -36.54M | -24.18M | -40.19M | -46.2M | -63.49M | -59.71M | -40.78M | -36.3M | -10.38M |
Financial Cash Flow | -7.75M | -49.44M | -31.53M | -82.61M | -234.4M | -227.8M | -211.79M | -251.42M | -245.66M | -222.83M | -212.57M | -133.91M | -93.46M | -57.95M | -62.62M | -70.81M | -68.23M | -129.55M | -138.12M | -119.05M | -90.31M | -362.32M |
Net Cash Flow | 120.64M | 136.06M | 195.08M | 160.26M | 34.19M | 16.78M | 19.31M | -17.26M | -64.96M | -99.45M | 63.88M | -284K | 16.4M | -65.48M | -221.51M | -214.73M | -184.97M | -239.27M | -90.38M | 26.97M | 14.88M | 48.89M |
Free Cash Flow | 147.96M | 205.28M | 236.95M | 244.82M | 262.48M | 234.11M | 220.86M | 229.98M | 176.82M | 124.24M | 276.39M | 137.5M | 145.63M | 26.62M | -35.81M | 44.16M | 39.84M | 122.74M | 193.54M | 223.59M | 181.43M | 411.86M |
Adj. Free Cash Flow | 121.15M | 180.58M | 205M | 213.86M | 232.63M | 205.81M | 193.09M | 203.44M | 150.71M | 98.3M | 249.57M | 108.82M | 115.95M | -4.76M | -59.59M | 20.47M | 23.84M | 114.99M | 185.79M | 218.46M | 170.88M | 395.65M |
Maintenance CapEx | -21.98M | -42.74M | -51.91M | -29.92M | -29.92M | -9.16M | n/a | -29.45M | -29.45M | -29.45M | -29.45M | n/a | -11.86M | -20.86M | -30.14M | -38.74M | -34.25M | -25.26M | -27.75M | -19.15M | -11.78M | -11.78M |
Growth CapEx | -50.09M | -55.84M | -51.14M | -53.02M | -58.68M | -63.64M | -74.24M | -53.41M | -46.18M | -47.76M | -39.74M | -48.96M | -41.16M | -36.99M | -26.77M | -24.76M | -22.35M | -22.04M | -20.53M | -41.78M | -53.73M | -54.47M |
Owner Earnings | 198.06M | 261.12M | 288.09M | 297.83M | 321.16M | 297.75M | 295.1M | 283.39M | 223M | 172M | 316.12M | 186.46M | 186.79M | 63.61M | -9.03M | 68.92M | 62.2M | 144.78M | 214.07M | 265.37M | 235.15M | 466.33M |
Add to Watchlist
Select watchlists to add or remove AMRX